share_log

康諾亞-B:自願性公告 司普奇拜單抗注射液治療季節性過敏性鼻炎藥品上市許可申請獲國家藥品監督管理局受理

KEYMED BIO-B: VOLUNTARY ANNOUNCEMENT NEW DRUG APPLICATION OF STAPOKIBART INJECTION FOR THE TREATMENT OF SEASONAL ALLERGIC RHINITIS ACCEPTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION

Hong Kong Stock Exchange ·  Apr 30 08:15

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.